Both in Biotechnology
Cognition Therapeutics vs Cardiff Oncology
Over the past year CGTX returned −33.3% and CRDF returned −43.8%; their daily moves had a correlation of 0.21.
CGTX −33.3% CRDF −43.8%Growth of $1, one year, split-adjusted
| Metric | CGTX | CRDF |
|---|---|---|
| Price | $0.9544 | $1.17 |
| Market cap | $90.8M | $91.0M |
| Today | +1.71% | −2.50% |
| 1 month | −6.4% | +24.5% |
| 6 months | +60.5% | −24.5% |
| Year to date | −29.3% | −58.4% |
| 1 year | −28.2% | −43.2% |
| Revenue growth (YoY) | — | −14.0% |
| Gross margin | — | 100.0% |
| Net margin | — | −8882.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 179.2× |
| Net cash | $34.0M | $34.5M |
| Dividend yield | — | — |
| Volatility (60d) | 50.8% | 103.0% |
| Short % of float | 9.8% | 18.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).